Manufacturers Life Insurance Company, The Alaunos Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$102 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $38,373 - $116,056	-93,594 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.62 - $1.17 $58,028 - $109,504	93,594 New	93,594 $60,000
Q1 2022 May 20, 2022	SELL	$0.62 - $1.17 $18,713 - $35,314	-30,183 Reduced 24.38%	93,594 $61,000
Q4 2021 Feb 16, 2022	SELL	$1.09 - $1.89 $4,002 - $6,940	-3,672 Reduced 2.88%	123,777 $135,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $7,352 - $13,939	5,106 Added 4.17%	127,449 $232,000
Q2 2021 Aug 12, 2021	BUY	$2.63 - $3.67 $1,864 - $2,602	709 Added 0.58%	122,343 $323,000
Q1 2021 May 03, 2021	SELL	$2.82 - $5.6 $28,507 - $56,610	-10,109 Reduced 7.67%	121,634 $438,000
Q4 2020 Feb 12, 2021	BUY	$2.09 - $3.09 $8,341 - $12,332	3,991 Added 3.12%	131,743 $332,000
Q2 2020 Aug 10, 2020	BUY	$2.2 - $3.71 $33,620 - $56,696	15,282 Added 13.59%	127,752 $410,000
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $29,480 - $77,269	15,516 Added 16.0%	112,470 $276,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $13,295 - $18,008	-3,366 Reduced 3.36%	96,954 $458,000
Q3 2019 Nov 12, 2019	SELL	$4.13 - $6.94 $892 - $1,499	-216 Reduced 0.21%	100,320 $423,000
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $45,196 - $70,407	11,356 Added 12.73%	100,536 $586,000
Q1 2019 May 13, 2019	SELL	$2.0 - $4.4 $13,628 - $29,981	-6,814 Reduced 7.1%	89,180 $344,000
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $7,309 - $16,434	4,540 Added 4.96%	95,994 $180,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $29,999 - $43,405	-13,274 Reduced 12.67%	91,454 $293,000
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $10,268 - $16,796	3,400 Added 3.36%	104,728 $317,000
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $5,567 - $8,270	-1,609 Reduced 1.56%	101,328 $397,000
Q4 2017 Feb 08, 2018	BUY	$4.0 - $6.54 $1,424 - $2,328	356 Added 0.35%	102,937 $426,000
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $511,879 - $673,957	102,581	102,581 $630,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account